The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

Spirometry is a standard test doctors use to determine how well your lungs function. A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments.

GSK respiratory, immunology and inflammation research and development (R&D) global head and senior vice-president Kaivan ...

One of them is the COPD Assessment Test (CAT), which is a quick and easy test for patients to complete and provides a score that indicates the impact of the disease on their health status.

London: GSK plc has received approval from the US Food and Drug Administration (FDA) for Nucala (mepolizumab) as an add-on ...

The FDA has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain COPD patients whose disease isn't ...

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic granulomatosis with polyangiitis and ...

Both AATD and COPD are conditions that can lead to breathing ... Ph.D., lead researcher and senior author on the paper. "Our test provides an accurate, comprehensive and rapid genotyping solution ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.